PLIANT THERAPEUTICS, INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
PLIANT THERAPEUTICS, INC. (PLRX) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $1.82 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-11
- PLIANT THERAPEUTICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $1.82M, a 27.39% decline from fiscal 2024.
- PLIANT THERAPEUTICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $2.50M, a 1.21% increase from fiscal 2023.
- PLIANT THERAPEUTICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $2.48M, a 59.99% increase from fiscal 2022.
- PLIANT THERAPEUTICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $1.55M, a 43.11% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $1.82M 10-K · filed 2026-03-11 |
| 2024-12-31 | $2.50M 10-K · filed 2026-03-11 |
| 2023-12-31 | $2.48M 10-K · filed 2025-03-03 |
| 2022-12-31 | $1.55M 10-K · filed 2024-02-27 |
| 2021-12-31 | $1.08M 10-K · filed 2023-03-09 |
| 2020-12-31 | $513.00K 10-K · filed 2022-03-01 |
| 2019-12-31 | $570.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |